Brinzolamide Patent Expiration
Brinzolamide is Used for various methods of delivering the drug to the patient. It was first introduced by Sandoz Inc
Brinzolamide Patents
Given below is the list of patents protecting Brinzolamide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Azopt |
US5461081 (Pediatric) | Topical ophthalmic pharmaceutical vehicles |
Apr 24, 2013
(Expired) | Sandoz |
| Azopt | US5461081 | Topical ophthalmic pharmaceutical vehicles |
Oct 24, 2012
(Expired) | Sandoz |
| Azopt |
US5378703 (Pediatric) | Sulfonamides useful as carbonic anhydrase inhibitors |
Oct 01, 2012
(Expired) | Sandoz |
Brinzolamide's Family Patents
Explore Our Curated Drug Screens
Brinzolamide Generic API Manufacturers
Several generic applications have been filed for Brinzolamide. The first generic version for Brinzolamide was by Watson Laboratories Inc and was approved on Nov 27, 2020. And the latest generic version is by Padagis Us Llc and was approved on Jul 28, 2023.
Given below is the list of companies who have filed for Brinzolamide generic, along with the locations of their manufacturing plants worldwide.
1. BAUSCH AND LOMB
Bausch And Lomb Inc has filed for 1 generic for Brinzolamide. Given below are the details of the strengths of this generic introduced by Bausch And Lomb.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | suspension/drops | Prescription | OPHTHALMIC | AB | Aug 18, 2021 |
Manufacturing Plant Locations New
Bausch And Lomb's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bausch And Lomb as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
2. PADAGIS US
Padagis Us Llc has filed for 1 generic for Brinzolamide. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | suspension/drops | Prescription | OPHTHALMIC | AB | Jul 28, 2023 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Brinzolamide. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | suspension/drops | Prescription | OPHTHALMIC | AB | Nov 27, 2020 |